Home » Cardiovascular » REDUCE-IT: CV risk reduction with Icosapent ethyl for hypertriglyceridemia

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

2018, Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia, NEJM

REDUCE-IT: CV risk reduction with Icosapent ethyl for hypertriglyceridemia